A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer
一项评估舒尼替尼苹果酸盐联合每周一次紫杉醇、序贯多柔比星和每日口服环磷酰胺加粒细胞集落刺激因子（G-CSF）作为局部晚期或炎性乳腺癌新辅助化疗方案的安全性和有效性的II期研究
期刊:Clinical Breast Cancer
影响因子:2.5
doi:10.1016/j.clbc.2021.05.009
Symonds, Lynn; Jenkins, Isaac; Linden, Hannah M; Kurland, Brenda; Gralow, Julie R; Gadi, Vijayakrishna V K; Ellis, Georgiana K; Wu, Qian; Rodler, Eve; Chalasani, Pavani; Chai, Xiaoyu; Riedel, Jinny; Scca Network Investigators; Stopeck, Alison; Brown-Glaberman, Ursa; Specht, Jennifer M
